Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05572632 · ClinicalTrials.gov registry record · NA
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
A NA study of COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 387
- Enrollment target
- 3
- Study locations
NCT05572632 is a NA study of COPD (Chronic Obstructive Pulmonary Disease) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 387 participants, below the 692-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (44% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05572632, a NA study of COPD (Chronic Obstructive Pulmonary Disease), is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 387 participants
- Enrollment target
- 3
- Study locations
Study Summary
Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, implementation of this resource-intensive program in real-life settings, and in particular, for underserved communities, has proven to be challenging. Safety-net centers that serve primarily under-insured populations lack financial resources to provide pulmonary rehabilitation. The 10-week COPD Wellness and Plus+ Program directly addresses this gap, and yet, programs like these do not automatically lead to improved outcomes, which leads to the implementation of a Health Advocates program to address participant's social needs and barriers to healthcare.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL COPD Wellness
- BEHAVIORAL COPD Wellness Plus+
Study Locations (3)
California
- Zuckerberg San Francisco General (ZSFG) Hospital - San Francisco
- Maxine Hall Health Center (MHHC) - San Francisco
- Southeast Health Center (SEHC) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 387 participants |
| Start Date | 2023-01-19 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05572632
The ClinicalTrials.gov registry entry for NCT05572632 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 387 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 692-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (44% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COPD (Chronic Obstructive Pulmonary Disease) appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.
NCT05572632 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05572632 about?
NCT05572632 is a clinical study titled "Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD". Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the course of COPD and improve outcomes, pulmonary rehabilitation is the one notable exception. However, im...
What is the current status of trial NCT05572632?
This trial is currently recruiting. It is a NA study. The enrollment target is 387 participants. The study started on 2023-01-19. Estimated completion is 2027-06-30.
What conditions does trial NCT05572632 study?
This clinical trial studies the following conditions: COPD (Chronic Obstructive Pulmonary Disease).
What interventions are being tested in trial NCT05572632?
The interventions under investigation include: Usual Care (BEHAVIORAL), COPD Wellness (BEHAVIORAL), COPD Wellness Plus+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT05572632?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05572632 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD (Chronic Obstructive Pulmonary Disease)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Photon-counting CT in Chest Imaging
RECRUITING · NA
-
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
RECRUITING · NA
-
OMEGA - Dietary Intervention - COPD Trial
RECRUITING · NA
-
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
RECRUITING
-
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.